Annals of Oncology 12:937-939, 2001
© 2001 European Society for Medical Oncology
research-article |
Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease
1Departments of Internal Medicine I, Division of Oncology Austria
2Internal Medicine IV, Division of Gastroenterology Austria
3Internal Medicine III, Division of Rheuinatolog Austria
4Otorhinolaryngology Austria
5Clinical Pathology, University of Vienna Austria
Markus Raderer. MD Department of Internal Medicine I Division of Oncology University of Vienna Waehringer Guertel 1820 A-1090 Vienna Austria E-mail markus.raderer{at}akh-wien.ac.at
Background and aims:: Gastric MALT-lymphoma is thought to be related to chronic antigenic stimulation provided by Helicobacter pylori (HP). As clonal expansion of gastric B cells not related to HP has been demonstrated in patients with auto- immune disease (AD), we have analysed whether AD ad versely influences response of MALTlymphoma following HP-eradication.
Patients and methods: Retrospective analysis of all patients with early stage gastric MALT-lymphoma treated with HP-eradication was performed. The presence of AD was evaluated by personal questioning for specific symptoms and serologically by analysis of rheumatoid factor, antinuclear antibodies and thyroid autoantibodies.
Results: A total of 22 patients were identified receiving only antibiotic treatment for initial management, and six presented with an autoimmune condition: three had Sjögren's syndrome, one polymyalgia rheumatica, one autoimmune thyroiditis along with psoriasis, and one patient had only autoimmune thyroiditis. Successful eradication of HP was achieved in all patients, and 15 of 22 patients (68%) achieved complete response of the lymphoma, while none out of the six patients with an autoimmune disorder responded to HP-eradication.
Conclusion: Apart from questioning the role of HP in the development of lymphoma in such patients, these results suggest that patients with autoimmune disease might not be optimal candidates for HP-eradication even in case of early stage lymphoma.
autoimmune disease, Helicohacter pylon, MALT lymphoma
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Maripuri, J. P. Grande, T. G. Osborn, F. C. Fervenza, E. L. Matteson, J. V. Donadio, and M. C. Hogan Renal Involvement in Primary Sjogren's Syndrome: A Clinicopathologic Study Clin. J. Am. Soc. Nephrol., September 1, 2009; 4(9): 1423 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. M. Ferreri, R. Dolcetti, M.-Q. Du, C. Doglioni, A. Giordano Resti, L. S. Politi, C. De Conciliis, J. Radford, F. Bertoni, E. Zucca, et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy Ann. Onc., May 1, 2008; 19(5): 835 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Raderer, B Streubel, S Wohrer, M Hafner, and A Chott Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas Gut, May 1, 2006; 55(5): 616 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Grunberger, W. Hauff, J. Lukas, S. Wohrer, C. C. Zielinski, B. Streubel, A. Chott, and M. Raderer 'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa Ann. Onc., March 1, 2006; 17(3): 484 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Streubel, D. Huber, S. Wohrer, A. Chott, and M. Raderer Frequency of Chromosomal Aberrations Involving MALT1 in Mucosa-Associated Lymphoid Tissue Lymphoma in Patients with Sjogren's Syndrome Clin. Cancer Res., January 15, 2004; 10(2): 476 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rollinson, A. P. Levene, F. K. Mensah, P. L. Roddam, J. M. Allan, T. C. Diss, E. Roman, A. Jack, K. MacLennan, M. F. Dixon, et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity Blood, August 1, 2003; 102(3): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eck, B. Schmausser, T. Kerkau, A. Greiner, M. Kraus, W. Fischbach, and H. K. Muller-Hermelink Autoantibodies in gastric MALT-type lymphoma Ann. Onc., July 1, 2003; 14(7): 1153 - 1154. [Full Text] [PDF] |
||||




